How and when do we use continuous renal replacement therapy for acute kidney injury in Serbia? - the multicentric survey

Author:

Knezevic Violeta1,Celic Dejan1,Azasevac Tijana1,Golubovic Sonja1ORCID,Sladojevic Vesna1,Nestorov Natasa1,Maksic Djoko1ORCID,Naumovic Radomir1,Lazarevic Tatjana1ORCID,Neskovic Vojislava1ORCID

Affiliation:

1. nema

Abstract

Background / Aim. Absence of clear guidance in the definition, diagnostics and indications for renal replacement treatment (RRT) is present. The aim of this survey is creating a unique strategy for diagnostics and treatment of acute kidney injury (AKI) based on the current clinical practice. Methods. ? Results. We have conducted a multicentric web-survey among nephrologists (46.8%) and other physicians in Serbia. The sample consisted of 119 participants, 78.9% out of which filled out the survey forms correctly, and were, therefore, included in the analysis. Most of them responded that the nephrologist indicates (76.8%) and prescribes (74.5%) of continuous renal replacement therapy (CRRT).The application of KDIGO 2 criterion for ?early? start of CRRT used 74.5% of the respondents, and 91.5% of them started ?late? initiation of CRRT in the presence of complications associated with AKI or poor response to conservative treatment. Regarding clinical experience of the respondents, 74.5% of them marked ?early? start of CRRT within 12 hours whereas 56.4% of them considered the start of CRRT after 48h as ?late?. The most commonly used modality was continuous venous hemodiafiltration (37.6%). Most participants used heparin as anticoagulant (95.7%) with average life span of filters less than 24 hours (71.3%) and 25 ml/kg/h efficiency target dialysis effluent dose (45.2%) during CRRT. The most common complications of CRRT were hypotension (55.3%) and catheter-related infections (29.8%). Conclusion. ?Early? start of CRRT is considered favorite by the majority of the participants. According to the obtained data, standardization of the strategy in the diagnostics and treatment of AKI is necessary.

Publisher

National Library of Serbia

Subject

Pharmacology (medical),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3